First Experience With BAK-free Travoprost 0.004% in Topical Glaucoma Medication

Clinical Ophthalmology - New Zealand
doi 10.2147/opth.s24983
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors
Publisher

Informa UK Limited

Related search

Efficacy, Safety, and Tolerability of Travoprost 0.004% BAK-free Versus Prior Treatment With Latanoprost 0.005% in Japanese Patients

Clinical Ophthalmology
Ophthalmology
2010English

A Randomized Crossover Study Comparing Tafluprost 0.005% With Travoprost 0.004% in Patients With Normal-Tension Glaucoma

Clinical Ophthalmology
Ophthalmology
2012English

Intraocular Pressure-Lowering Efficacy of Bimatoprost 0.03% and Travoprost 0.004% in Patients With Glaucoma or Ocular Hypertension

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2006English

Effects of Corneal Thickness on the Intraocular Penetration of Travoprost 0.004%

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2012English

Efficacy of the Travoprost/Timolol Fixed Combination Versus the Concomitant Use of Travoprost 0.004% and Timolol 0.1% Gel Formulation

Clinical Ophthalmology
Ophthalmology
2018English

Polyquad-Preserved Travoprost/Timolol, Benzalkonium Chloride (BAK)-preserved Travoprost/Timolol, and Latanoprost/Timolol in Fixed Combinations: A Rabbit Ocular Surface Study

Advances in Therapy
MedicinePharmacology
2011English

Sustainability of Intraocular Pressure Reduction of Travoprost Ophthalmic Solution in Subjects With Normal Tension Glaucoma

Advances in Therapy
MedicinePharmacology
2016English

Efficacy and Safety of Travoprost Alone or in Combination With Other Agents for Glaucoma and Ocular Hypertension: Patient Considerations

Clinical Ophthalmology
Ophthalmology
2010English

Rates of Glaucoma Medication Utilization Among Older Adults With Suspected Glaucoma, 1992 to 2002

American Journal of Ophthalmology
Ophthalmology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy